Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Lung Cancer

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.JTO.0000284285.39574.86PMID 17532092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.

  2007cited by this paper
• EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.

  2005cited by this paper
• Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System

  2005cited by this paper
• Promoter Hypermethylation Is the Predominant Mechanism in hMLH1 and hMSH2 Deregulation and Is a Poor Prognostic Factor in Nonsmoking Lung Cancer

  2005cited by this paper
• Differential DNA Hypermethylation of Critical Genes Mediates the Stage-Specific Tobacco Smoke-Induced Neoplastic Progression of Lung Cancer

  2005cited by this paper
• Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.

  2004cited by this paper
• Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung Cancer

  2004cited by this paper
• Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?

  2004cited by this paper
• Epidemiologic Considerations to Assess Altered DNA Methylation from Environmental Exposures in Cancer

  2003cited by this paper
• Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis.

  2003cited by this paper
• Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples.

  2003cited by this paper
• Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer

  2003cited by this paper
• Promoter hypermethylation of tumor suppressor and tumor‐related genes in non‐small cell lung cancers

  2003cited by this paper
• Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.

  2002cited by this paper
• Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

  2001cited by this paper
• DNA methylation profiles of lung tumors.

  2001cited by this paper
• Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

  2001cited by this paper
• 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.

  2001cited by this paper
• Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development.

  2001cited by this paper
• p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.

  2001cited by this paper
• DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

  2000cited by this paper
• Characteristics of lung cancer in Korea, 1997.

  2000cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.

  1998cited by this paper
• Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

  1998cited by this paper
• Frequent aberrant methylation of p16INK4a in primary rat lung tumors

  1997cited by this paper
• Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure.

  1996cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• An epidemiological study of risk factors for lung cancer in Guangzhou, China.

  1996cited by this paper

• Multi-omics immune regulatory mechanisms in lung adenocarcinoma metastasis and survival time

  2023cites this paper
• Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma

  2023cites this paper
• Synergistic Effects of Different Levels of Genomic Data for the Staging of Lung Adenocarcinoma: An Illustrative Study

  2021cites this paper
• The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer

  2020cites this paper
• GSTP1 and cancer: Expression, methylation, polymorphisms and signaling (Review).

  2020cites this paper
• A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma

  2019cites this paper
• Hypermethylation of MDFI promoter with NSCLC is specific for females, non-smokers and people younger than 65

  2018cites this paper
• GSTP1 methylation in cancer: a liquid biopsy biomarker?

  2018cites this paper
• Does adenomatous polyposis coli gene promoter 1A methylation increase non‐small cell lung cancer risk? A meta‐analysis

  2017cites this paper
• The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review

  2016cites this paper
• Tumour biomarkers: homeostasis as a novel prognostic indicator

  2016cites this paper
• The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review

  2016cites this paper
• MLH 1 promoter methylation in non-small cell lung cancer : a meta-analysis

  2016cites this paper
• The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review

  2016cites this paper
• Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers.

  2016cites this paper
• Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer

  2016cites this paper
• The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review

  2016cites this paper
• Epigenetics of lung cancer.

  2015cites this paper
• Persistent organic pollutants and promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene

  2015cites this paper
• Epigenetic biomarkers in lung cancer.

  2014cites this paper
• Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer

  2014cites this paper
• Associations Between RASSF 1 A Promoter Methylation and NSCLC : A Meta-analysis of Published Data

  2013influential citation
• Association between MGMT Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis

  2013cites this paper
• Association between P16INK4a Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis

  2013cites this paper
• Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation

  2013cites this paper
• Genetic and epigenetic alterations of the LKB1 gene and their associations with mutations in TP53 and EGFR pathway genes in Korean non-small cell lung cancers.

  2013cites this paper
• CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non–Small-Cell Lung Cancer

  2013cites this paper
• Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data.

  2013influential citation
• CDKN 2 A / p 16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non – Small-Cell Lung Cancer

  2013cites this paper
• The role of DNA methylation as biomarkers in the clinical management of lung cancer

  2013cites this paper
• Promoter methylation and loss of p16INK4a gene expression in head and neck cancer

  2012cites this paper
• DNA甲基化在肺癌早期诊断中的研究进展

  2012cites this paper
• DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancer

  2012cites this paper
• Nuclear Translocation of Acinetobacter baumannii Transposase Induces DNA Methylation of CpG Regions in the Promoters of E-cadherin Gene

  2012cites this paper
• Promoter methylation of the RGC32 gene in nonsmall cell lung cancer

  2011cites this paper
• Cigarette Smoking and p16INK4α Gene Promoter Hypermethylation in Non-Small Cell Lung Carcinoma Patients: A Meta-Analysis

  2011cites this paper
• Hypomethylation of the thymosin β10 gene is not associated with its overexpression in non-small cell lung cancer

  2011cites this paper
• DNA methylation in thoracic neoplasms.

  2011cites this paper
• Comparison of genetic and epigenetic alterations at 11 tumor suppressor loci in pulmonary sclerosing hemangioma and adenocarcinoma

  2011influential citation
• MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases

  2011cites this paper
• Chronic exposure to cigarette smoke condensate in vitro induces epithelial to mesenchymal transition-like changes in human bronchial epithelial cells, BEAS-2B.

  2011cites this paper
• Association of 5'-CpG island hypermethylation of the FHIT gene with lung cancer in southern-central Chinese population

  2010cites this paper
• Effect of age on the association between p16CDKN2A methylation and DNMT3B polymorphism in head and neck carcinoma and patient survival.

  2010cites this paper
• Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic features.

  2010cites this paper
• Analysis of microsatellite instability, protein expression and methylation status of hMLH1 and hMSH2 genes in gastric carcinomas.

  2009cites this paper
• Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features.

  2009cites this paper
• DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update

  2008cites this paper
• Epigenetic regulation of human epithelial cell cancers.

  2008cites this paper
• CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.

  2008cites this paper
• Epigenetic effects of lung cancer predisposing factors impact on clinical diagnosis and prognosis

  2008cites this paper
• Molecular biology of lung cancer: clinical implications.

  2002cites this paper